These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26548552)

  • 1. Interaction Studies of Withania Somnifera's Key Metabolite Withaferin A with Different Receptors Assoociated with Cardiovascular Disease.
    Ravindran R; Sharma N; Roy S; Thakur AR; Ganesh S; Kumar S; Devi J; Rajkumar J
    Curr Comput Aided Drug Des; 2015; 11(3):212-21. PubMed ID: 26548552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
    Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
    BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
    Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
    Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
    Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
    Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
    Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
    J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
    [No Abstract]   [Full Text] [Related]  

  • 6. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
    Purushotham PM; Kim JM; Jo EK; Senthil K
    Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of VEGF: a novel mechanism to control angiogenesis by Withania somnifera's key metabolite Withaferin A.
    Saha S; Islam MK; Shilpi JA; Hasan S
    In Silico Pharmacol; 2013; 1():11. PubMed ID: 25505656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
    Vadloori B; Sharath AK; Prabhu NP; Maurya R
    BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopy.
    Namdeo AG; Sharma A; Yadav KN; Gawande R; Mahadik KR; Lopez-Gresa MP; Kim HK; Choi YH; Verpoorte R
    Planta Med; 2011 Nov; 77(17):1958-64. PubMed ID: 21728148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withaferin A and its potential role in glioblastoma (GBM).
    Dhami J; Chang E; Gambhir SS
    J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
    Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
    Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withaferin A, a polyfunctional pharmacophore that includes covalent engagement of IPO5, is an inhibitor of influenza A replication.
    Patouret R; Barluenga S; Winssinger N
    Bioorg Med Chem; 2022 Sep; 69():116883. PubMed ID: 35772286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating anticancer properties of Withaferin A-a potent phytochemical.
    Atteeq M
    Front Pharmacol; 2022; 13():975320. PubMed ID: 36339589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
    Kumar S; Singh R; Gajbhiye N; Dhanani T
    J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
    [No Abstract]   [Full Text] [Related]  

  • 15. On the action and mechanism of withaferin-A from Withania somnifera, a novel and potent melanin dispersing agent in frog melanophores.
    Ali SA; Meitei KV
    J Recept Signal Transduct Res; 2011 Oct; 31(5):359-66. PubMed ID: 21848494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the potential of withanolides as Phosphodiesterase-4 (PDE4D) inhibitors.
    Rathi A; Kumar V; Sundar D
    J Biomol Struct Dyn; 2023 Apr; 41(6):2108-2117. PubMed ID: 35060432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of Withaferin A nanoparticles extracted from Withania somnifera by the expansion of supercritical fluid solution.
    Karimi M; Raofie F
    Phytochem Anal; 2020 Nov; 31(6):957-967. PubMed ID: 32666662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera.
    Sivasankarapillai VS; Madhu Kumar Nair R; Rahdar A; Bungau S; Zaha DC; Aleya L; Tit DM
    Environ Sci Pollut Res Int; 2020 Jul; 27(21):26025-26035. PubMed ID: 32405942
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
    Trivedi MK; Panda P; Sethi KK; Jana S
    Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.